Anton Hagenbeek, MD, PhD of the University of Amsterdam, Netherlands highlights the sessions on novel immunotherapies and liquid biopsies from the 2016 International Workshop on Non-Hodgkin Lymphoma (iwNHL) meeting held in San Diego, CA. Prof. Hagenbeek mentions CAR T-cells, the new generation of antibodies and new checkpoint inhibitors, as well as the session on the detection of tumor DNA in the circulation and minimal residual disease (MRD).